SCHEMBL7709004

SCHEMBL7709004

CCOC(=O)CCCOc1ccccc1C(=O)OCC

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.57
TBXAS1 P24557 1/20 0.55
L3MBTL1 Q9Y468 4/20 0.55
TDP1 Q9NUW8 3/20 0.55
ALDH1A1 P00352 2/20 0.50
ABCB1 P08183 1/20 0.50
HSD17B10 Q99714 1/20 0.50
MAPT P10636 3/20 0.49
LMNA P02545 2/20 0.49
CYP3A4 P08684 2/20 0.48
MEN1 O00255 1/20 0.48
NR1I2 O75469 1/20 0.48
CHRM2 P08172 1/20 0.48
ADRA2A P08913 1/20 0.48
OPRK1 P41145 1/20 0.48
HTR2B P41595 1/20 0.48
SLC6A3 Q01959 1/20 0.48
KMT2A Q03164 1/20 0.48
HDAC6 Q9UBN7 1/20 0.48
HSP90AA1 P07900 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4877407 0.92 MAPT (0.57) TSHRTBXAS1L3MBTL1TDP1ALDH1A1
SCHEMBL7075294 0.88 TSHR (0.57) TSHRTBXAS1L3MBTL1TDP1ALDH1A1
SCHEMBL7072045 0.88 TSHR (0.50) TSHRTBXAS1L3MBTL1TDP1ALDH1A1
SCHEMBL5353531 0.86 TSHR (0.65) TSHRTBXAS1L3MBTL1TDP1ALDH1A1
Methyl Salicylate SCHEMBL4573550 0.86 LMNA (0.54) TSHRL3MBTL1TDP1ALDH1A1ABCB1
SCHEMBL28748376 0.85 TSHR (0.53) TSHRTBXAS1L3MBTL1TDP1ALDH1A1
SCHEMBL10459135 0.85 TSHR (0.61) TSHRTBXAS1L3MBTL1TDP1ALDH1A1
SCHEMBL9969538 0.84 TSHR (0.65) TSHRTBXAS1L3MBTL1TDP1ALDH1A1
SCHEMBL6042513 0.84 TSHR (0.59) TSHRTBXAS1L3MBTL1TDP1ALDH1A1
SCHEMBL11588678 0.84 TSHR (0.59) TSHRTBXAS1L3MBTL1TDP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6369110-B1 PROPHYLACTIC AGENT FOR DISEASES CAUSED BY THE ACCELERATION OF THE SODIUM/PROTON EXCHANGE TRANSPORT SYSTEM SUMITOMO PHARMACEUTICALS COMPANY (JP) 2002-04-09 US disclosed
EP-1083166-A1 NOVEL SUBSTITUTED GUANIDINE DERIVATIVES AND PROCESS FOR PRODUCING THE SAME SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2001-03-14 EP disclosed